Climb Bio, Inc. Announces $110.0 Million Private Placement

Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, ...

Climb Bio (CLYM) Receives FDA Fast Track Designation for Budoprutug in Rare Kidney Disease

Climb Bio Inc (NASDAQ:CLYM) is one of the tiny stocks that are on fire right now. On April 7, Climb Bio received FDA Fast ...

Nuvation Bio, Inc. Class A

View Nuvation Bio, Inc. Class A NUVB stock quote prices, financial information, real-time forecasts, and company news from CNN.
Nasdaq

Climb Bio, Inc. Appoints Perrin Wilson, Ph.D. as Chief Business Officer

Climb Bio appointed Dr. Perrin Wilson as Chief Business Officer to strengthen its leadership in developing immune-mediated disease treatments. Climb Bio, Inc. has announced the appointment of Dr.
Nasdaq

Nuvation Bio Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Nuvation Bio Inc. (NYSE: NUVB). The investigation focuses on whether ...

Intelligent Bio Solutions Inc.

View Intelligent Bio Solutions Inc. INBS stock quote prices, financial information, real-time forecasts, and company news from CNN.
PharmiWeb

Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies

New program matches top researchers with expert service providers trained to offer a comprehensive suite of Shasta® ...